Ipriflavone
Ipriflavone has been studied in 1 paper since 2016: none in people yet, 1 in animals. The research so far is in animals. The newest paper, Jan 1, 2016: “The Protective and Therapeutic Effect of Exclusive and Combined Treatment with Alpha-ketoglutarate Sodium Salt and Ipriflavone on Bone Loss in Orchidectomized Rats”.
See all 2 papers on ipriflavone
At a glance
The findings reach mice, none yet in people. 1 lab in 2 countries.
Mice: a single group. Cells, worms or flies and humans: nothing yet.
- 1 lab in 2 countries
- Animals1
What did studies of ipriflavone find?
1Studies of ipriflavone measured one outcome, osteopenia.
Osteopenia
downin rats1
1 study
Osteopenia
downin rats1
Ipriflavone prevents osteopenia in rats (applied alone, during development of osteopenia after orchidectomy).
“during the development of osteopenia, AKG and IP when applied exclusively, counteracts osteopenia development”
Animalsapplied alone, during development of osteopenia after orchidectomytibia50 mg/kg b.w.60 daysmales
The journal of nutrition, health & aging
Latest
The Journal of Nutrition, Health & Aging
The Protective and Therapeutic Effect of Exclusive and Combined Treatment with Alpha-ketoglutarate Sodium Salt and Ipriflavone on Bone Loss in Orchidectomized Rats
Experiments in 128 ratsBone loss